Thomson Medical - Public Comps and Valuation Multiples

Thomson Medical Overview

About Thomson Medical

Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.

Founded

1999

HQ

Employees

669

Website

thomsonmedical.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $312M

LTM EBITDA $52.9M

EV

$2.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Thomson Medical Financials

As of September 2025, Thomson Medical reported last 12-month revenue of $312M and EBITDA of $52.9M.

In the same period, Thomson Medical achieved -$24.1M in LTM net income.

See Thomson Medical valuation multiples based on analyst estimates

Thomson Medical P&L

In the most recent fiscal year, Thomson Medical reported revenue of $304M and EBITDA of $44.4M.

Thomson Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Thomson Medical valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$312M	XXX	$304M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$227M	XXX	XXX	XXX
Gross Margin	n/a	XXX	75%	XXX	XXX	XXX
EBITDA	$52.9M	XXX	$44.4M	XXX	XXX	XXX
EBITDA Margin	17%	XXX	15%	XXX	XXX	XXX
EBIT	$23.8M	XXX	-$29.8M	XXX	XXX	XXX
EBIT Margin	8%	XXX	-10%	XXX	XXX	XXX
Net Profit	-$24.1M	XXX	-$36.6M	XXX	XXX	XXX
Net Margin	-8%	XXX	-12%	XXX	XXX	XXX
Net Debt	XXX	XXX	$755M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Thomson Medical including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $312M. EBITDA for the last twelve months was $52.9M. In the most recent fiscal year, Thomson Medical achieved $304M in revenue and $44.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$312M	Analyst estimates available to subscribers	$304M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$227M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	74.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$52.9M	Analyst estimates available to subscribers	$44.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	16.9% EBITDA margin	Analyst estimates available to subscribers	14.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$23.8M	Analyst estimates available to subscribers	-$29.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	7.6% EBIT margin	Analyst estimates available to subscribers	-9.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$24.1M	Analyst estimates available to subscribers	-$36.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-7.7% net profit margin	Analyst estimates available to subscribers	-12.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$755M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Thomson Medical

This financial data table provides comprehensive performance metrics for Thomson Medical, a company based in Singapore. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Thomson Medical generated $312M in revenue over the last twelve months.
The company achieved $52.9M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$24.1M.

Fiscal Year Performance

In the most recent fiscal year, Thomson Medical reported $304M in total revenue.
Fiscal year EBITDA was $44.4M.
The company maintained a gross profit margin of 74.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 14.6%.
Net profit margin reached -12.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Thomson Medical. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Thomson Medical Stock Performance

Thomson Medical has current market cap of SGD 1.6B (or $1.2B), and EV of SGD 2.6B (or $2.0B).

Market Cap Evolution

Thomson Medical Stock Data

As of October 17, 2025, Thomson Medical's stock price is SGD 0 (or $0).

See Thomson Medical trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.0B	$1.2B	XXX	XXX	XXX	XXX	$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Thomson Medical Valuation Multiples

Thomson Medical's trades at 6.9x EV/Revenue multiple, and 30.6x EV/EBITDA.

See valuation multiples for Thomson Medical and 15K+ public comps

Thomson Medical Financial Valuation Multiples

As of October 17, 2025, Thomson Medical has market cap of $1.2B and EV of $2.0B.

Equity research analysts estimate Thomson Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Thomson Medical has a P/E ratio of -49.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.2B	XXX	$1.2B	XXX	XXX	XXX
EV (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV/Revenue	6.3x	XXX	6.9x	XXX	XXX	XXX
EV/EBITDA	37.2x	XXX	30.6x	XXX	XXX	XXX
EV/EBIT	82.7x	XXX	503.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-49.8x	XXX	-97.1x	XXX	XXX	XXX
EV/FCF	n/a	XXX	58.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Thomson Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Thomson Medical Margins & Growth Rates

Thomson Medical's last 12 month revenue growth is 8%

Thomson Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Thomson Medical's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Thomson Medical's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Thomson Medical and other 15K+ public comps

Thomson Medical Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	9%	XXX	XXX	XXX
EBITDA Margin	17%	XXX	22%	XXX	XXX	XXX
EBITDA Growth	51%	XXX	12%	XXX	XXX	XXX
Rule of 40	31%	XXX	31%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	37%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.5M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	85%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial